- Home
- CIGI vs GKOS Comparison
CIGI vs GKOS Comparison
Compare CIGI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGI
- GKOS
- Stock Information
- Founded
- CIGI 1972
- GKOS 1998
- Country
- CIGI Canada
- GKOS United States
- Employees
- CIGI N/A
- GKOS N/A
- Industry
- CIGI
- GKOS Medical/Dental Instruments
- Sector
- CIGI
- GKOS Health Care
- Exchange
- CIGI Nasdaq
- GKOS Nasdaq
- Market Cap
- CIGI 8.0B
- GKOS 7.4B
- IPO Year
- CIGI N/A
- GKOS 2015
- Fundamental
- Price
- CIGI $143.98
- GKOS $140.84
- Analyst Decision
- CIGI Buy
- GKOS Strong Buy
- Analyst Count
- CIGI 4
- GKOS 12
- Target Price
- CIGI $160.38
- GKOS $135.08
- AVG Volume (30 Days)
- CIGI 111.8K
- GKOS 600.2K
- Earning Date
- CIGI 11-05-2024
- GKOS 11-04-2024
- Dividend Yield
- CIGI 0.21%
- GKOS N/A
- EPS Growth
- CIGI 586.57
- GKOS N/A
- EPS
- CIGI 3.10
- GKOS N/A
- Revenue
- CIGI $4,555,575,000.00
- GKOS $360,347,000.00
- Revenue This Year
- CIGI $11.69
- GKOS $22.68
- Revenue Next Year
- CIGI $12.25
- GKOS $24.98
- P/E Ratio
- CIGI $46.50
- GKOS N/A
- Revenue Growth
- CIGI 5.40
- GKOS 18.70
- 52 Week Low
- CIGI $101.01
- GKOS $59.22
- 52 Week High
- CIGI $156.96
- GKOS $145.84
- Technical
- Relative Strength Index (RSI)
- CIGI 40.26
- GKOS 56.37
- Support Level
- CIGI $140.13
- GKOS $135.74
- Resistance Level
- CIGI $145.51
- GKOS $144.99
- Average True Range (ATR)
- CIGI 4.13
- GKOS 5.25
- MACD
- CIGI -1.01
- GKOS 0.02
- Stochastic Oscillator
- CIGI 22.88
- GKOS 76.46
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc is a real estate services and investment management company. The company provides commercial real estate professional services and investment management to corporate and institutional clients around the world. It's primary service lines are Outsourcing & Advisory, Investment Management, Leasing and Capital Markets. Operationally, company is organized into four distinct segments: Americas; Europe, Middle East and Africa, Asia and Australasia and Investment Management.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.